- Samsung Medison, a medical device unit of Samsung Electronics that specialises in developing diagnostic imaging devices, said on Wednesday it plans to acquire Sonio.
- The French startup’s AI assistant assists obstetricians and gynecologists with ultrasound exams and has FDA 510(k) clearance for Sonio Detect.
- Samsung Medison said Sonio’s software would help it bring better AI-driven imaging workflows to the market.
Samsung Medison, a medical device unit of Samsung Electronics, plans to acquire Sonio, a Paris-based startup specialising in AI-powered software for ultrasound workflows, for about $92.7 million.
Also read: AI advances bring Samsung’s memory chip business back to life
Sonio helps bring AI-driven imaging workflow
Samsung Medison said Sonio’s software would help it bring better AI-driven imaging workflows to the market. Samsung Electronics, which owns a 68.45% stake in the medical device unit, acquired Medison for $22 million in 2011.
Samsung said in a statement that following the acquisition, Sonio will remain an independent company and continue to grow commercially and offer products and services in France.
Also read: Samsung says AI will drive technology demand in second half
Sonia stays optimism
Co-founded by Cecile Brosset and Remi Besson in 2020, Sonio most recently secured $14 million in a Series A led by Cross Border Impact Ventures in August 2023. The company has raised a total of $27.2 million, according to Tracxn, and its investors include Elaia, Bpifrance French Tech Seed, OneRagtime, and a few angel investors.
“Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology,” said Yong Kwan Kim, CEO of Samsung Medison. “Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”
